SCAPHIO
DEAD

Serial Number

85922510

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

May 3, 2013

Add to watchlist:

No watchlists yet
View on USPTO

SCAPHIO Trademark

Serial Number: 85922510

SCAPHIO is a trademark filed by NOVARTIS AG on May 3, 2013. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

May 3, 2013

Registration Date

Not Registered

Published for Opposition

October 8, 2013

Goods & Services

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the musculo-skeletal system and the genitourinary system; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jan 4, 2016 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 4, 2016 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 5, 2015 EXRA
SOU EXTENSION 3 GRANTED
Jun 4, 2015 EX3G
SOU EXTENSION 3 FILED
May 22, 2015 EXT3
SOU TEAS EXTENSION RECEIVED
May 22, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 17, 2015 EXRA
SOU EXTENSION 2 GRANTED
Jan 16, 2015 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 15, 2015 AITU
SOU EXTENSION 2 FILED
Nov 29, 2014 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 29, 2014 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 31, 2014 EXRA
SOU EXTENSION 1 GRANTED
May 29, 2014 EX1G
SOU EXTENSION 1 FILED
May 29, 2014 EXT1
SOU TEAS EXTENSION RECEIVED
May 29, 2014 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 3, 2013 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 8, 2013 NPUB
PUBLISHED FOR OPPOSITION
Oct 8, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 18, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 3, 2013 PREV
ASSIGNED TO LIE
Sep 3, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 23, 2013 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 23, 2013 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 23, 2013 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 23, 2013 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 23, 2013 CNEA
ASSIGNED TO EXAMINER
Aug 21, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 10, 2013 NWOS
NEW APPLICATION ENTERED
May 7, 2013 NWAP